Emerging Omicron Subvariants BA.2.12.1, BA.4 and BA.5 are Inhibited Less Efficiently by Antibodies
The Omicron subvariants BA.1 and BA.2 of SARS-CoV-2 have dominated the COVID-19 pandemic in early 2022. In many countries, these viruses are now outcompeted by emerging subvariants, with BA.5 being…